LBA3 Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (aNSCLC): CheckMate 227 - part 2 final analysis

著者: Luis Paz‐Ares, Tudor–Eliade Ciuleanu, Xiaolu Yu, Pamela Salman, Adam Płużański, Adnan Nagrial, Libor Havel, Rubén Dario Kowalyszyn, Clarisse Audigier-Valette, Yi‐Long Wu, Hossein Borghaei, Matthew D. Hellmann, Julie R. Brahmer, Martin Reck, Sundar Ramalingam, L. Zhang, Prabhu Bhagavatheeswaran, Faith E. Nathan, Kenneth J. O’Byrne - Annals of Oncology 2019 被引用: 48